Cytokinetics Announces Upcoming Presentations at the 2022
Two Late Breaking Clinical Trials Sessions to Feature New Data from REDWOOD-HCM OLE...
Stay updated with breaking news from Dosing With. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Two Late Breaking Clinical Trials Sessions to Feature New Data from REDWOOD-HCM OLE...
Echocardiographic Data Show Treatment with Aficamten for 10 Weeks Results In Improved Cardiac Structure, Myocardial Relaxation and Mitral Valve Mechanics SOUTH SAN FRANCISCO, Calif., June 13, 2022 ... | June 13, 2022
SOUTH SAN FRANCISCO, Calif., June 03, 2022 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that additional results from a...
03.06.2022 - SOUTH SAN FRANCISCO, Calif., June 03, 2022 (GLOBE NEWSWIRE) - Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that additional results from a new analysis from REDWOOD-HCM (Randomized Evaluation of Dosing With CK-274 in Obstructive ... Seite 1
23.05.2022 - Data from Up to Six Months of Treatment with Aficamten Show Significant and Sustained Reductions in LVOT Gradients with Improvements in Functional Class, Symptoms, and Biomarkers Analyses from GALACTIC-HF Show Patients with Low Blood Pressure Have ... Seite 1